Corporate Tech Investors

Dexcom

Dexcom is a corporate venture capital group that partners with startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class - while empowering our community to take control of diabetes.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/19/2024

Transaction History

Our records indicate that Dexcom invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

John Burd

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Dexcom has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Dexcel Pharma | Dexxon Groupe

Share this article

About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary